Determination of the structure of a decay accelerating factor-binding clinical isolate of echovirus 11 allows mapping of mutants with altered receptor requirements for infection.
about
Inhibition of coxsackie B virus infection by soluble forms of its receptors: binding affinities, altered particle formation, and competition with cellular receptors.Mapping CD55 function. The structure of two pathogen-binding domains at 1.7 AThe structure of echovirus type 12 bound to a two-domain fragment of its cellular attachment protein decay-accelerating factor (CD 55)The Crystal Structure of a Coxsackievirus B3-RD Variant and a Refined 9-Angstrom Cryo-Electron Microscopy Reconstruction of the Virus Complexed with Decay-Accelerating Factor (DAF) Provide a New Footprint of DAF on the Virus SurfaceThe Enterovirus 71 A-particle Forms a Gateway to Allow Genome Release: A CryoEM Study of Picornavirus UncoatingDistinguishing molecular features and clinical characteristics of a putative new rhinovirus species, human rhinovirus C (HRV C).Pathogenesis of Afa/Dr diffusely adhering Escherichia coli.Widespread circulation of echovirus type 13 demonstrated by increased seroprevalence in Toyama, Japan, between 2000 and 2003.Identification of a structural motif in the tumor-suppressive protein GRIM-19 required for its antitumor activityInteraction of alphaVbeta3 and alphaVbeta6 integrins with human parechovirus 1.Pathogenesis of human diffusely adhering Escherichia coli expressing Afa/Dr adhesins (Afa/Dr DAEC): current insights and future challengesMolecular analysis of echovirus 13 isolates and aseptic meningitis, SpainDecay-accelerating factor binding determines the entry route of echovirus 11 in polarized epithelial cells.The spike protein VP4 defines the endocytic pathway used by rotavirus to enter MA104 cells.Enhanced cellular receptor usage by a bioselected variant of coxsackievirus a21.Metabolomics of Rhabdomyosarcoma Cell During Echovirus 30 Infection.Resistance of Echovirus 11 to ClO2 Is Associated with Enhanced Host Receptor Use, Altered Entry Routes, and High Fitness.Novel role for decay-accelerating factor in coxsackievirus A21-mediated cell infectivity.Structural and functional insights into the interaction of echoviruses and decay-accelerating factor.Enterovirus capsid interactions with decay-accelerating factor mediate lytic cell infection.Prevalent human coxsackie B-5 virus infects porcine islet cells primarily using the coxsackie-adenovirus receptor.Evolution of echovirus 11 in a chronically infected immunodeficient patient.
P2860
Q24533362-AA9C2D93-3991-4DAE-938A-0400BCD00960Q27640215-41A48528-EA51-41D4-A9C6-701D33B0A332Q27642610-17E71C0A-78AF-4779-9C3A-432C37A52C84Q27673022-8BEA0B17-16E8-4400-A908-F2B71D250CD2Q27677204-319F4719-72C3-49FF-AB70-20C511ADB56CQ31151268-1D678437-EF44-48B2-A995-A29B67FC1058Q33755215-5AD1A0B5-B83D-4341-B18F-DCEED346C6F2Q33825693-7A5546BF-9A73-45B1-B915-CE982FCF5BB8Q34033341-7D3E7D9E-40C2-4690-A571-78B37AE5B2B2Q34055408-591521F9-4203-458C-99F4-9C653D47E984Q34297628-F443B56A-022E-4228-8297-5FE9D3DC4D80Q34488267-1AFA7F36-5113-4A37-8E82-CC5CF06A3921Q35531685-16E1B4CF-D571-460F-B2B7-A2A5A904248AQ36559900-32091165-D617-4818-B719-6E42BA7E3CE7Q37596657-2B47008E-F07F-4C08-9520-6169187C0651Q38696258-6D0A305E-A9A2-4927-86AA-67F6142A731CQ40072274-7BEBB6CC-1DAA-4EA5-A8F0-1F4D94394C8BQ40278584-896E2D29-C3B9-4FF8-BACC-DA9D4D036A36Q40354189-2CE4957B-1DBB-470A-BE41-207BFF5450C4Q40468698-FFA5D5FC-D75B-45AD-A735-B58E86ADBAD2Q45566693-132560CD-C915-4B38-944B-06FF9A89FBA0Q52648772-22D39AFC-957D-46F9-92BB-A956F7C72C0F
P2860
Determination of the structure of a decay accelerating factor-binding clinical isolate of echovirus 11 allows mapping of mutants with altered receptor requirements for infection.
description
2002 nî lūn-bûn
@nan
2002 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Determination of the Structure ...... tor Requirements for Infection
@nl
Determination of the structure ...... or requirements for infection.
@ast
Determination of the structure ...... or requirements for infection.
@en
type
label
Determination of the Structure ...... tor Requirements for Infection
@nl
Determination of the structure ...... or requirements for infection.
@ast
Determination of the structure ...... or requirements for infection.
@en
prefLabel
Determination of the Structure ...... tor Requirements for Infection
@nl
Determination of the structure ...... or requirements for infection.
@ast
Determination of the structure ...... or requirements for infection.
@en
P2093
P2860
P1433
P1476
Determination of the structure ...... or requirements for infection.
@en
P2093
Amanda D Stuart
Chris Harley
Pamela A Williams
T David K Brown
Thomas A McKee
P2860
P304
P356
10.1128/JVI.76.15.7694-7704.2002
P577
2002-08-01T00:00:00Z